Critical care sedation for neuroscience patients

Journal of the Neurological Sciences
M A Mirski, Mitzi K Hemstreet


In 2000, the Joint Commission on Accreditation of Healthcare Organizations (JCAHO) introduced the mandate for the implementation of standards for both pain assessment and need for therapy in hospitalized patients. The need for the appropriate titration of sedation and analgesia is particularly poignant in an intensive care unit (ICU) setting where iatrogenic discomfort often complicates patient management. Neurologically ill patients in ICUs present particularly complex sedation issues, owing to the need to monitor these patients with serial neurological exams. Hence, maximal comfort without diminishing neurological responsiveness is desirable. Here, we review the frequently applied methods of evaluating levels of pain and agitation in critically ill patients as well as discuss the appropriate classes of pharmaceutical agents common to this population, with particular emphasis on the potential neurophysiological impact of such therapy.


Apr 1, 1979·The Journal of Nervous and Mental Disease·R C HallE R Gardner
May 1, 1979·Journal of Clinical Pharmacology·C T ViswanathanP G Welling
Jan 1, 1975·Drug Metabolism Reviews·U Boerner
Feb 1, 1991·British Journal of Clinical Pharmacology·S KarhuvaaraM Scheinin
Jan 1, 1991·Therapeutic Drug Monitoring·P A Glare, T D Walsh
Jan 1, 1990·Acta Anaesthesiologica Scandinavica. Supplementum·J Schulte am Esch, E Kochs
Dec 1, 1990·Anaesthesia·S J MackenzieI S Grant
Dec 28, 1987·Life Sciences·G W PasternakC E Inturrisi
Aug 15, 1986·Science·A PfeifferH M Emrich
Sep 1, 1988·British Journal of Anaesthesia·K A LehmannJ Heykants
Apr 1, 1988·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·P J SimonsM Rowland
Jan 1, 1985·European Journal of Clinical Pharmacology·G NordbergT Mellstrand
Jun 22, 1974·British Medical Journal·M A RamsayR Goodwin
Jan 1, 1968·The American Journal of Psychiatry·S Jacobson
Aug 1, 1981·The Journal of Pharmacy and Pharmacology·S Bower
Sep 1, 1983·Clinical Pharmacokinetics·L E Mather
Jun 1, 1983·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·A ForsterD Morel
Jul 1, 1983·Anesthesiology·A M Safwat, D Daniel
May 1, 1984·Anesthesia and Analgesia·J M MurkinC M Epstein
Sep 1, 1981·Psychosomatics·M M GehiW L Webb
Dec 1, 1995·Critical Care Medicine·M A MirskiD F Hanley
Nov 1, 1994·Anesthesia and Analgesia·V LischkeJ Vettermann
Jul 1, 1993·The American Journal of the Medical Sciences·A W Longmire, D L Seger
Dec 1, 1993·Journal of Clinical Pharmacology·A FujimuraT Kotegawa
Jun 1, 1994·Anesthesia and Analgesia·P L Pitt-MillerM Maharaj
Jul 1, 1993·Anesthesia and Analgesia·A J de ArmendiJ F Ryan
Jul 1, 1993·Brain Injury : [BI]·J W AtchisonJ D Corrigan
Sep 1, 1993·Epilepsia·J P MäkeläM Lahdensuu
May 1, 1997·European Journal of Anaesthesiology. Supplement·A Borgeat
Aug 1, 1997·Anesthesia and Analgesia·P TalkeC A Richardson
Nov 14, 1997·Anesthesia and Analgesia·P TalkeD M Fisher
Jan 14, 1998·Harvard Review of Psychiatry·H Sternbach, R State
Sep 18, 1998·Clinical Pharmacokinetics·H Russo, F Bressolle
Oct 30, 1998·The Annals of Pharmacotherapy·L A Brown, G M Levin
Jul 17, 1999·Journal of Neurology, Neurosurgery, and Psychiatry·M Matsuura
Nov 24, 1999·British Journal of Anaesthesia·Y MiyazakiH Segawa
Feb 15, 2000·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·S B Patten, C I Neutel
Aug 31, 2000·Critical Care Medicine·N D PerrierM J Murray
Dec 16, 2000·Journal of Nippon Medical School = Nippon Ika Daigaku Zasshi·K MaruyamaR Ogawa
Mar 10, 2001·The Journal of Clinical Psychiatry·A PredaM B Bowers
Mar 17, 2001·Clinical and Experimental Pharmacology & Physiology·H Tsuchiya
Jul 11, 2001·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·F M Besag
Oct 26, 2001·Postgraduate Medical Journal·N D HawkesG Shortland
Feb 6, 2002·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·American College of Critical Care Medicine of the Society of Critical Care Medicine, American Society of Health-System Pharm
Mar 13, 2002·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Francesco PisaniRaoul Di Perri
Apr 9, 2002·QJM : Monthly Journal of the Association of Physicians·H R Cock, A H V Schapira
Jul 26, 2002·Acta Anaesthesiologica Scandinavica·I DobrydnjovB Holmström
Aug 28, 2002·The Annals of Pharmacotherapy·Tep M Kang
Sep 10, 2002·Anesthesiology·Robert A WhittingtonHisayo O Morishima
Sep 28, 2002·Anesthesia and Analgesia·Richard C PrielippJohn Butterworth
Aug 9, 2003·Intensive Care Medicine·Beatrice VasileNicola Latronico
May 29, 2004·Current Opinion in Critical Care·D Kyle Hogarth, Jesse Hall
Aug 10, 2005·Seminars in Respiratory and Critical Care Medicine·E W ElyS K Inouye


Mar 13, 2008·Current Treatment Options in Neurology·Mark T Keegan
Feb 3, 2009·The Lancet Oncology·Augusto Caraceni, Fabio Simonetti
Mar 14, 2017·Journal of Pain & Palliative Care Pharmacotherapy·John Bodnar
Feb 1, 2019·Journal of Neural Engineering·Ancor Sanz-GarcíaGuillermo J Ortega
Jan 30, 2015·Journal of Clinical Neurophysiology : Official Publication of the American Electroencephalographic Society·Susan T HermanCritical Care Continuous EEG Task Force of the American Clinical Neurophysiology Society
May 1, 2018·Brain Injury : [BI]·Leana MahmoudLinda C Wendell
Jul 29, 2016·Medical Science Monitor : International Medical Journal of Experimental and Clinical Research·Dapeng HouWei Zheng

Related Concepts

Care of Intensive Care Unit Patient
Subacute Delirium
Dose-Response Relationship, Drug
Drug Interactions
Monitoring, Physiologic
Nervous System Disorder
Anti-Anxiety Effect

Related Feeds


Bradyarrhythmias are slow heart rates. Symptoms may include syncope, dizziness, fatigure, shortness of breath, and chest pains. Find the latest research on bradyarrhythmias here.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

CSF & Lymphatic System

This feed focuses on Cerebral Spinal Fluid (CSF) and the lymphatic system. Discover the latest papers using imaging techniques to track CSF outflow into the lymphatic system in animal models.


Anaphylaxis is a serious allergic reaction that is rapid in onset and may cause death.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.


An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.


Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.